Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 109 Neoplasms 99 Lung Neoplasms 60 Colorectal Neoplasms 45 Prostatic Neoplasms 40 Carcinoma, Non-Small-Cell Lung 39 Pancreatic Neoplasms 33 Melanoma 31 Head and Neck Neoplasms 27 Neoplastic Cells, Circulating 25 Ovarian Neoplasms 24 Uterine Cervical Neoplasms 20 Sarcoma 19 Multiple Myeloma 19 Glioma 19 Colonic Neoplasms 19 Carcinoma, Hepatocellular 17 Leukemia, Myeloid, Acute 16 Neoplasm Metastasis 15 Squamous Cell Carcinoma of Head and Neck 14 Lymphoma 14 Glioblastoma 14 Esophageal Neoplasms 14 Endometrial Neoplasms 14 Leukemia 12 Kidney Neoplasms 11 Hematologic Neoplasms 11 Gastrointestinal Neoplasms 11 Carcinoma, Renal Cell 11 Myelodysplastic Syndromes 10

Interventions

Gemcitabine 15 Doxorubicin 8 Docetaxel 8 Radiotherapy 7 Trabectedin 6 Nivolumab 5 pazopanib 4 liposomal doxorubicin 3 Sunitinib 3 Dacarbazine 3 pembrolizumab 2 eribulin 2 durvalumab 2 avelumab 2 Specimen Handling 2 Radiation Dose Hypofractionation 2 Letrozole 2 Ifosfamide 2 Bevacizumab 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 tremelimumab 1 temsirolimus 1 sotigalimab 1 selinexor 1 sargramostim 1 rucaparib 1 ribociclib 1 regorafenib 1 pegfilgrastim 1 olaratumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leiomyosarcoma × Blood Specimen Collection × Clear all

NCT04925089 2026-02-17

Localized Leiomyosarcoma Biomarker Protocol

University of Michigan Rogel Cancer Center

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡